Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-08 Sale | 2023-11-08 8:31 pm | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 1,811 | $0.33 | $598 | 28,759 (Direct) | View |
| 2023-11-02 Sale | 2023-11-03 4:11 pm | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 3,999 | $0.33 | $1,320 | 42,570 (Direct) | View |
| 2023-08-08 Sale | 2023-08-09 8:42 pm | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 2,004 | $9.51 | $19,058 | 22,069 (Direct) | View |
| 2023-05-08 Sale | 2023-05-10 9:31 pm | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 38,531 | $0.1255 | $4,836 | 91,469 (Direct) | View |
| 2021-06-02 Purchase | 2021-06-04 5:00 pm | Centessa Pharmaceuticals plc | CNTA | Thorell Marella Chief Accounting Officer | 1,000 | $20 | $20,000 | 1,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-01 Option Award | 2024-07-01 7:19 pm | N/A 2034-07-01 | Carisma Therapeutics Inc. | CARM | Thorell Marella Director | 38,700 | $0 | 38,700 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-28 12:40 pm | 2025-03-25 2034-03-25 | ESSA Pharma Inc. | EPIX | Thorell Marella Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 4:20 pm | N/A 2034-03-24 | Seres Therapeutics Inc. | MCRB | Thorell Marella See Remarks | 700,000 | $0 | 700,000 (Direct) | View |
| 2023-11-07 Exercise | 2023-11-08 8:31 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 6,500 | $0 | 28,759 (Direct) | View |
| 2023-11-01 Exercise | 2023-11-03 4:11 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 12,500 | $0 | 42,570 (Direct) | View |
| 2023-09-11 Option Award | 2023-09-13 8:55 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 37,500 | $0 | 37,500 (Direct) | View |
| 2023-08-07 Exercise | 2023-08-09 8:42 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 6,500 | $0 | 22,069 (Direct) | View |
| 2023-05-07 Exercise | 2023-05-09 4:09 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 130,000 | $0 | 520,000 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 4:25 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 520,000 | $0 | 520,000 (Direct) | View |
| 2022-12-13 Other | 2022-12-15 4:26 pm | N/A N/A | Vallon Pharmaceuticals Inc. | VLON | Thorell Marella Director | 28,517 | $0 | 38,023 (Direct) | View |
| 2022-06-29 Option Award | 2022-11-01 11:08 am | N/A 2032-06-29 | ESSA Pharma Inc. | EPIX | Thorell Marella Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-01 4:52 pm | N/A 2032-09-01 | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 440,000 | $0 | 440,000 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 2:03 pm | N/A N/A | Vallon Pharmaceuticals Inc. | VLON | Thorell Marella Director | 38,023 | $0 | 38,023 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 1:31 pm | N/A 2032-06-09 | Vallon Pharmaceuticals Inc. | VLON | Thorell Marella Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2022-03-21 Other | 2022-03-23 4:56 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Thorell Marella Chief Accounting Officer | 52,101 | $0 | 105,202 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 6:30 pm | N/A 2032-02-01 | Centessa Pharmaceuticals plc | CNTA | Thorell Marella Chief Accounting Officer | 67,500 | $0 | 67,500 (Direct) | View |
| 2021-01-29 Option Award | 2021-06-01 8:47 pm | N/A 2030-09-30 | Centessa Pharmaceuticals plc | CNTA | Thorell Marella Chief Accounting Officer | 414,417 | $0 | 414,417 (Direct) | View |
Ownership | 2021-05-27 8:25 pm | N/A 2030-09-30 | Centessa Pharmaceuticals plc | CNTA | Thorell Marella Chief Accounting Officer | 0 | $0 | 276,917 (Direct) | View |
| 2021-02-12 Option Award | 2021-02-12 6:01 pm | N/A 2031-02-12 | Vallon Pharmaceuticals Inc. | VLON | Thorell Marella Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-12-11 Option Award(A) | 2021-01-26 7:03 pm | N/A 2030-12-11 | ESSA Pharma Inc. | EPIX | Thorell Marella Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2020-12-11 Option Award | 2021-01-11 4:46 pm | N/A 2030-12-11 | ESSA Pharma Inc. | EPIX | Thorell Marella Director | 16,500 | $0 | 16,500 (Direct) | View |
Ownership | 2020-10-01 7:04 pm | N/A N/A | ESSA Pharma Inc. | EPIX | Thorell Marella Director | 0 | $0 | 52,881 (Direct) | View |